HER2 Status by Standardized Immunohistochemistry and Silver-Enhanced In Situ Hybridization in Korean Breast Cancer

PURPOSE: Amplification of the human epidermal growth factor receptor 2 (HER2) gene occurs in 18% to 20% of breast cancers, and it is recognized as a prognostic and predictive marker. We investigated the HER2 status in Korean breast cancer by immunohistochemistry (IHC) and silver-enhanced in situ hyb...

Descripción completa

Detalles Bibliográficos
Autores principales: Bae, Young Kyung, Gong, Gyungyub, Kang, Jun, Lee, Ahwon, Cho, Eun Yoon, Lee, Ji Shin, Suh, Kwang-Sun, Lee, Dong Wha, Jung, Woo Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3542844/
https://www.ncbi.nlm.nih.gov/pubmed/23346165
http://dx.doi.org/10.4048/jbc.2012.15.4.381

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3542844/
https://www.ncbi.nlm.nih.gov/pubmed/23346165
http://dx.doi.org/10.4048/jbc.2012.15.4.381

Ejemplares similares